NCT04574375

Brief Summary

The primary objective of this study is to assess in real-life settings the effectiveness of conservative treatments on symptoms, signs and quality of life, in patients consulting for CVD

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,419

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 15, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 15, 2020

Completed
20 days until next milestone

First Posted

Study publicly available on registry

October 5, 2020

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
Last Updated

October 6, 2023

Status Verified

December 1, 2022

Enrollment Period

1.8 years

First QC Date

September 15, 2020

Last Update Submit

October 3, 2023

Conditions

Keywords

observationnalQoL

Outcome Measures

Primary Outcomes (4)

  • Global leg symptoms severity

    Measured by visual analogue scale (VAS) and questioning with 4 points rate

    week 4

  • Global improvement

    Measured by Patient Global Impression of Change (PGIC) scale, and time to improvement.

    Week 4

  • Disease severity

    Measured by VCSS (Venous Clinical Severity score)

    Week 4

  • Quality of Life

    Measured by CIVIQ-14 questionnaire

    Week 4

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Male and female patients consulting spontaneously or referred for symptomatic CVD not requiring surgical treatment

You may qualify if:

  • Age ≥18 years old
  • Patient consulting spontaneously or referred for symptomatic venous disorders
  • Diagnosis of chronic venous disease according to investigator's judgment

You may not qualify if:

  • Presence of known severe systemic disease likely to interfere with the study evaluation
  • Patients with lower limb arterial disease
  • Patient with any other concomitant disease or treatment that may interfere with lower limb pain or edema
  • Patient consulting for an emergency not related to venous disease
  • Patient currently taking any treatment for chronic venous disorders, either with venoactive drug or with compression hosiery
  • Procedure or surgery for venous disease planned during the study
  • Pregnant or breastfeeding woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Servier Affaires Medicales

Suresnes, 92284, France

Location

Related Publications (1)

  • Mezalek ZT, Feodor T, Chernukha L, Chen Z, Rueda A, Sanchez IE, Ochoa AJG, Chirol J, Blanc-Guillemaud V, Lohier-Durel C, Ulloa JH. VEIN STEP: A Prospective, Observational, International Study to Assess Effectiveness of Conservative Treatments in Chronic Venous Disease. Adv Ther. 2023 Nov;40(11):5016-5036. doi: 10.1007/s12325-023-02643-6. Epub 2023 Sep 20.

Related Links

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 15, 2020

First Posted

October 5, 2020

Study Start

June 15, 2020

Primary Completion

March 31, 2022

Study Completion

March 31, 2022

Last Updated

October 6, 2023

Record last verified: 2022-12

Locations